Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus

Clinical trial NCT06485674 · COMPLETED

Trial details

NCT number: NCT06485674
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus

Start date: 2024-05-09
Primary completion: 2025-06-24
Enrollment: 561

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.